| When Cells Go Rogue: Controlling Tumor Growth. CONNECT. David Cheresh, Ph.D. Professor, Pathology; Associate Director, Translational Research; Moores Cancer Center, UC San Diego. Dr. Cheresh's laboratory studies tumor angiogenesis and tumor cell invasion and metastasis. They have developed a number of inhibitors of tumor angiogenesis that are now being tested clinically in cancer patients. Two of these agents, Vitaxin and Celingitide, show promise for late stage cancer patients and appear safe with little or no side effects. This lecture will spotlight their research efforts, primarily dealing with the study of molecular mechanisms that regulate tumor cell and endothelial cell survival, migration and invasion. See http://www.connect.org |
RSS